Vertex Pharmaceuticals Incorporated announced today that a reimbursement agreement was signed with the GKV-Spitzenverband for its CRISPR/Cas9 gene-edited therapy, CASGEVY® (exagamglogene autotemcel).
Every day, generous blood donors help ensure patients and their families get more precious time together. Approaching ...
If you haven’t figured out what you’re getting the mothers in your life for mother’s day, you’d better get on it — it’s this Sunday. And there’s not a whole lot better or more appropriate gift than ...
WXII 12 will hold a Community Blood Drive on Thursday, May 28 at College Park Baptist Church.
Two high school-ers in Delta are encouraging community members and residents from surrounding areas to donate blood at their ...
For the first time, scientists at University of Leeds reveal a complex mechanism behind blood clotting. The findings, ...
The agreement ensures sustainable access to this innovative therapy for eligible patients ages 12 years and older in Germany- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results